The Lactate/Albumin Ratio serves as a valuable biomarker for predicting delirium risk in critically ill patients with acute heart failure.
Does the lactate/albumin ratio predict delirium risk in critically ill patients with acute heart failure?
The lactate/albumin ratio may serve as a useful biomarker to predict delirium risk in critically ill patients with acute heart failure, potentially enabling timely interventions.
Our findings suggest that LAR is a valuable biomarker for predicting delirium risk in critically ill acute heart failure patients. Recognizing at-risk patients may enable timely interventions to mitigate delirium and improve ICU outcomes. Further research is warranted to validate these findings and explore targeted management strategies.
Yan et al. (2026) studied this question. The Lactate/Albumin Ratio serves as a valuable biomarker for predicting delirium risk in critically ill patients with acute heart failure.